Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo


Unsupported browser: Your browser does not meet modern web standards. See how it scores »

{ action.text }

The first genome-wide scan of an African-American population is under way, as scientists look for genetic clues about diseases such as obesity, hypertension, and diabetes in the population group. These diseases, says Charles Rotimi, an epidemiologist at Howard University, have higher rates of incidence in African Americans compared with European Americans. With this study, he hopes to identify the genetic factors that may contribute to these higher incidence rates.

Rotimi and Michael Christman, a geneticist at Boston University School of Medicine, plan to sample the DNA of 1,500 African Americans in the Washington, D.C. area. They will then look for key genetic differences between individuals who are, for example, obese and not obese. Small alterations in the genetic code, if shared by a significant number in the sample of overweight individuals, could serve as genetic markers for obesity.

One goal of the study is to better understand how the complex interactions of genetics and environmental factors lead to the high incidences of the diseases. In previous work, Rotimi, director of the National Human Genome Center at Howard University, has found that hypertension rates vary widely in populations with African ancestry, depending on where such people now live. That is, black populations in rural West Africa show a low rate of hypertension (7 percent). Those in the Caribbean have significantly higher incidences (28 percent), while African Americans have even higher incidences (34 percent). The difference, Rotimi suspects, is a combination of a person’s environment and genetics, and he hopes that the genome-wide scan will provide important clues about the contribution of each.

That’s where Michael Christman comes in. Christman, chair of the Genetics and Genomics Department at Boston University, recently identified specific regions of the genome associated with obesity in a sample mainly of European Americans. After scanning the genomes of 1,320 people–participants in a long-running, multigenerational study called the Framingham Heart Study–he found that those who were obese shared common variations in their DNA.

Christman and Rotimi hope to similarly identify DNA variations in African Americans that may code them for a propensity toward obesity, hypertension, and diabetes. The researchers plan to analyze blood samples from the Washington, D.C., group using the latest in gene-chip technology from Affymetrix, a leading genetic microarray company. The gene-chip technology maps highly dense and complex regions of DNA. Researchers will use the chip to finely map specific areas of the genome in search of meaningful variations.

“Even though the increase in obesity has an environmental cause–for example, caloric excess and sedentary behavior–that environment is laid down on a foundation of genetics, which is at least half of your propensity for obesity,” says Christman. “It’s sort of a set point, a high and low range for an individual [propensity] for obesity.”

1 comment. Share your thoughts »

Tagged: Biomedicine

Reprints and Permissions | Send feedback to the editor

From the Archives


Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me